Home » Topics » Regulatory

Regulatory
RSS

Femara receives new U.S. approval

Dec. 30, 2005

Revlimid receives FDA approval

Dec. 29, 2005

Orencia approved for rheumatoid arthritis

Dec. 28, 2005

Nexavar receives FDA approval for advanced renal cell carcinoma

Dec. 22, 2005

Depakote ER receives new approval in bipolar disorder

Dec. 19, 2005

Iplex approved for severe primary IGF-1 deficiency

Dec. 15, 2005

Korean approval for udenafil in erectile dysfunction

Dec. 1, 2005

U.K. approval for MT-100 for migraine

Nov. 29, 2005

Metvix approved for Bowen's disease in Europe

Nov. 29, 2005

Effexor XR approved for adults with panic disorder

Nov. 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...